BI-RG-587 Is Active Against Zidovudine-Resistant Human Immunodeficiency Virus Type 1 and Synergistic With Zidovudine.
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.35.2.305
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 1991
Authors
Publisher
American Society for Microbiology